International Clinical Trial: What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210034) titled 'What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes' on Sept. 29.

Study Type: Observational

Primary Sponsor: Assiut University

Condition: Myelo Dysplastic Syndrome

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07210034

Published by HT Digital Content Services with permission from Health Daily Digest....